Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston blog main
3
×
boston top stories
clinical trials
fda
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
3
×
biotech ipos
boston
national
acute myeloid leukemia
aligos therapeutics
alx oncology
antibiotics
arvinas
astrazeneca
autoimmune diseases
baker brothers life sciences
benzodiazepine
berkeley lights
blackstone group
blepharitis
boulder/denver
boulder/denver blog main
boulder/denver top stories
cancer drugs
cancer immunotherapy
carbapenem-resistant enterobacteriaceae
cavion
cd47
celgene
cephalgia
chronic hepatitis b virus
chronic kidney disease
david goldstein
What
ipos
3
×
biotechs
ipo
life
research
science
way
week
arrival
biotech
central
chose
close
cns
companies
company
days
device
disorder
drugs
emerged
firms
hasn’t
industry
kept
leads
make
market
medical
medicines
momentum
nervous
new
open
praxis
precision
prep
q
quarter
quiet
Language
unset
Current search:
ipos
×
photo
×
fda
×
" san francisco top stories "
×
" boston blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way